Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Arcus Biosciences (RCUS) Equity Ratio: 2017-2025

Historic Equity Ratio for Arcus Biosciences (RCUS) over the last 8 years, with Sep 2025 value amounting to 0.45.

  • Arcus Biosciences' Equity Ratio rose 3.00% to 0.45 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.45, marking a year-over-year increase of 3.00%. This contributed to the annual value of 0.42 for FY2024, which is 0.04% down from last year.
  • Per Arcus Biosciences' latest filing, its Equity Ratio stood at 0.45 for Q3 2025, which was down 12.35% from 0.51 recorded in Q2 2025.
  • Arcus Biosciences' 5-year Equity Ratio high stood at 0.71 for Q1 2021, and its period low was 0.42 during Q4 2024.
  • For the 3-year period, Arcus Biosciences' Equity Ratio averaged around 0.47, with its median value being 0.46 (2025).
  • In the last 5 years, Arcus Biosciences' Equity Ratio declined by 27.36% in 2022 and then increased by 14.06% in 2024.
  • Arcus Biosciences' Equity Ratio (Quarterly) stood at 0.53 in 2021, then decreased by 4.45% to 0.51 in 2022, then declined by 16.52% to 0.42 in 2023, then fell by 0.04% to 0.42 in 2024, then grew by 3.00% to 0.45 in 2025.
  • Its Equity Ratio was 0.45 in Q3 2025, compared to 0.51 in Q2 2025 and 0.46 in Q1 2025.